Strongbridge Biopharma Plc (SBBP) Return on Assets ROA from the second quarter of 2021 to second quarter of 2020 and for the year 2021, Average High and Low, Fundamental Ratios from Jun 30 2021 to Jun 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Strongbridge Biopharma plc  (NASDAQ: SBBP)


Strongbridge Biopharma Plc's ROA from the second quarter of 2021 to the second quarter of 2020 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Strongbridge Biopharma Plc's ROA in the second quarter of 2021?
Strongbridge Biopharma Plc recorded a cumulative net loss of $-40 million during 12 months ending in the second quarter of 2021, resulting in a negative return on assets (ROA) of -35.16%.

However, within the Healthcare sector 574 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the first quarter of 2021 from 4156 to 4205.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2021)
II. Quarter		 (Mar 31 2021)
I. Quarter		 (Dec 31 2020)
IV. Quarter		 (Sep 30 2020)
III. Quarter		 (Jun 30 2020)
II. Quarter
Y / Y Total Assets Change -0.83 % 6.92 % 2.65 % -4.33 % -27.74 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -40 -44 -45 -42 -53
Return On Assets (TTM) -35.16 % -38.62 % -40.01 % -37.66 % -46.62 %
SBBP's Total Ranking # 4205 # 4156 # 4591 # 4016 # 4162
Total Assets (TTM) in million 97 108 134 118 98
Seq. Total Assets Change -10.39 % -19.57 % 14.19 % 20.5 % -3.39 %
Seq. Net Income Change - - - - -

SBBP's 5 Years Annual ROA >> Back to SBBP Management Effectiveness >> Compare SBBP ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 236
Sector # 575
Overall # 4081

Return On Assets Statistics
High Average Low
29.96 %
-44.56 %
-108.68 %
(Sep 30 2019)   (Dec 31 2017)





Financial Statements
Strongbridge Biopharma Plc's Assets $ 97 million SBBP's Balance sheet
Strongbridge Biopharma Plc's Income $ -13 million Quarterly SBBP's Income Statement
SBBP's Income by Division See SBBP's Income by Division



Annual Return On Assets (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
Y / Y Total Assets Change 2.65 % -31.4 % 25.07 % 16.04 % -20.44 %
Total Assets in million 134 131 191 153 131
Y / Y Net Income Change - - - - -
Net Income in million -45 -49 32 -113 -49
Annual Return On Assets -33.55 % -37.78 % 16.7 % -74.4 % -37.06 %

SBBP's 5 Years Annual ROA >> Back to SBBP Management Effectiveness >> Compare SBBP ROA to its Competitors



More Return On Assets Ratios
SBBP's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
SBBP's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for SBBP's Competitors
Subscribers only: Roa for Strongbridge Biopharma Plc's Suppliers
Subscribers only: Return On Assets for SBBP's Customers

You may also want to know
SBBP's Roi SBBP's Inventory Turnover Ratio SBBP's Growth Rates SBBP's Dividend Comparisons
SBBP's Profitability Ratios SBBP's Asset Turnover Ratio SBBP's Dividend Growth
SBBP's Roe SBBP's Valuation Ratios SBBP's Financial Strength Ratios SBBP's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2021, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:20+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.